The University of Chicago Header Logo

Connection

Sonali Smith to Antineoplastic Agents, Immunological

Back to Details
This is a "connection" page, showing publications Sonali Smith has written about Antineoplastic Agents, Immunological.
Sonali Smith
Connection Strength
0.120
Antineoplastic Agents, Immunological
  1. Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials. Lancet Haematol. 2017 Apr; 4(4):e176-e182.
    View in: PubMed
    Score: 0.120
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.